This is a preview of subscription content, log in via an institution to check access.
References
Berger G, van den Berg E, Sikkema-Raddatz B, Abbott KM, Sinke RJ, Bungener LB et al. Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation. Leukemia 2017; 31: 520–522.
Polprasert C, Schulze I, Sekeres MA, Makishima H, Przychodzen B, Hosono N et al. Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer Cell 2015; 27: 658–670.
Wiseman DH . Donor cell leukemia: a review. Biol Blood Marrow Transplant 2011; 17: 771–789.
Hahn CN, Ross DM, Feng J, Beligaswatte A, Hiwase DK, Parker WT et al. A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone. Leukemia 2015; 29: 2101–2104.
Hirsch P, Mamez AC, Belhocine R, Lapusan S, Tang R, Suner L et al. Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation. Leukemia 2016; 30: 1756–1759.
Gondek LP, Zheng G, Ghiaur G, DeZern AE, Matsui W, Yegnasubramanian S et al. Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation. Leukemia 2016; 30: 1916–1920.
Bulycheva E, Rauner M, Medyouf H, Theurl I, Bornhauser M, Hofbauer LC et al. Myelodysplasia is in the niche: novel concepts and emerging therapies. Leukemia 2015; 29: 259–268.
Adams PD, Jasper H, Rudolph KL . Aging-induced stem cell mutations as drivers for disease and cancer. Cell Stem Cell 2015; 16: 601–612.
Naro C, Bielli P, Pagliarini V, Sette C . The interplay between DNA damage response and RNA processing: the unexpected role of splicing factors as gatekeepers of genome stability. Front Genet 2015; 6: 142.
Acknowledgements
We thank the patient’s family for their trust.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Kobayashi, S., Kobayashi, A., Osawa, Y. et al. Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation. Leukemia 31, 1020–1022 (2017). https://doi.org/10.1038/leu.2017.44
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.44
- Springer Nature Limited
This article is cited by
-
Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines
International Journal of Hematology (2024)
-
Genomic testing for germline predisposition to hematologic malignancies
Blood Research (2024)
-
DDX41 germline variants causing donor cell leukemia indicate a need for further genetic workup in the context of hematopoietic stem cell transplantation
Blood Cancer Journal (2023)
-
A case of donor cell leukemia driven by a de novo NRAS mutation with complex karyotype
Annals of Hematology (2023)
-
Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations
International Journal of Hematology (2023)